Hence, studies that explore modalities that affect COMP expression, alleviate extracellular matrix rigidity and lung restriction in IPF and interfere with the amplification of TGF-β1 signaling should be persuaded. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.